AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca koselugo (selumetinib) — Established RoW YoY CER (%) (%)
Form 6-K / 20-F Product Sales Table
Latest, Q2 2026
90.0%
Period ended Jun 30, 2026
Change on a year earlier
+68.0 pts
22.0% in Q2 2025
History
18 quarters
Since Q4 2020
Sources
18
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). AstraZeneca Koselugo (selumetinib) — Established RoW YoY CER (%) (%), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/med_koselugo_erow_cer_yoy
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.